PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG wins new strategic investor for growth financing

Friday, 21. August 2020 12:55

Public disclosure of inside information according to article 17 MAR

Graefelfing, Munich (pta021/21.08.2020/12:55) - With Peter Möhrle Holding, the family office of the Peter Möhrle entrepreneur family, Dr. Hönle AG wins a new strategic investor for Hönle Group's growth financing.

In order to implement the participation of the new anchor shareholder, today, Dr. Hönle AG resolved to increase the Company's nominal capital from currently Eur 5,512,930 by Eur 550,000 to Eur 6,062,930 by issuing 550,000 new shares, making use of the Company's existing authorised capital.
The capital increase will be effected against a cash contribution and with the exclusion of shareholders' subscription rights. The newly issued shares will represent 9.1% of the share capital of Dr. Hönle AG after the implementation of the capital increase. The new shares will be issued at an issue price of Eur 48.20 per share in close orientation to the stock exchange price. They will be taken over in full by a wholly-owned (100%) subsidiary of Peter Möhrle Holding as the new anchor investor. The new shares are entitled to dividends from 1 October 2019 and will be included in the existing listing on the regulated market of the Frankfurt Stock Exchange.

In all, the Company will receive gross issuance proceeds of Eur 26,510,000 from the capital increase. The proceeds are to be used to finance further growth of the Hönle Group. This also includes corporate acquisitions.

About Peter Möhrle Holding
Peter Möhrle Holding is the family office of the Peter Möhrle entrepreneur family with a registered office in Hamburg. The holding company is active in three focal areas: corporate investments, asset management and real estate investments. Within the scope of its corporate investment activities, the holding company regularly supports medium-sized companies in the development of their internationalisation strategies, the opening up of new sales markets and realisation of organic and inorganic growth. The holding company originates mainly from the contribution of the sales proceeds from the sale of the Max Bahr DIY chain to Praktiker AG in 2007.
About Hönle
The Dr. Hönle AG is a listed technology company based in Gräfelfing near Munich. With more than 500 employees, the Hönle Group develops innovative solutions for a wide variety of industrial manufacturing processes. A main focus of the business activity is the development and sale of industrial adhesives and sealings. Furthermore, devices for drying inks and coatings, curing adhesives and plastics as well as for surface disinfection and sunlight simulation are manufactured. In addition, the company produces UV lamps for water disinfection and produces tubes and semi-finished products made of quartz glass, which are used in different industries. The Hönle Group supplies technology and world market leaders and is represented in more than 20 countries by own companies and sales partners.

(end)

emitter: Dr. Hönle AG
address: Lochhamer Schlag 1, 82166 Gräfelfing/München
country: Germany
contact person: Peter Weinert
phone: +49 89 85608-173
e-mail: peter.weinert@hoenle.de
website: www.hoenle.de

ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate

[ source: http://www.pressetext.com/news/20200821021 ]

Related Links: Dr. Hönle AG
Author: